Kim Rodriguez is the President, CEO & Co-Founder of Acessa Health. Previously, she served as President & CEO of Halt Medical. Prior to Halt, she was Senior Vice President of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Prior to Spectranetics, Kim served in a series of global senior leadership roles across sales, marketing, therapy development and general business management at Johnson & Johnson, Blockade Medical acquired by Balt International, Concentric Medical acquired by Stryker Neurovascular, Guidant Corporation acquired by Abbott Vascular and Microvena acquired by ev3. Over the course of a 20+ year career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the commercialization of dozens of innovative MedTech technologies and M&A transactions. Kim received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.